CLINICAL EVALUATION OF CEFMENOXIME IN THE INTERNAL MEDICINE, WITH SPECIAL REFERENCE TO INFECTION: ASSOCIATED WITH HEMATOLOGICAL DISORDERS

Clinical evaluation of cefmenoxime (CMX, Bestcall® ) was performed against infections associated with hematological, respiratory tract and other disorders. Clinical effectiveness of CMX against severe infectionswith hematological disorders including sepsis, pneumonia, pyelitis and so on was 74. 4% f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese journal of antibiotics 1986/05/25, Vol.39(5), pp.1250-1258
Hauptverfasser: KAWAMURA, SETSUKO, SAKATA, YU, CHIBA, YOICHI, YOSHIDA, YUTAKA, KANAZAWA, TETSUO, KAWAZU, SHUNTARO, TSUGE, MITSUO, TANABE, KAZUHIKO, NARA, HIDEYASU, AIZAWA, MICHIRO, KOMATSU, YOSHIHIKO, YAMAGATA, AKIYOSHI, SEGAWA, MASANOBU, FUKUSI, KATSUHISA, OKAMOTO, KATSUHIRO, OHMI, TADANAO, HIGUCHI, KENSHIRO, SUGAWARA, YASUO, AOYAMA, HITOSHI, FUJIWARA, SHIRO, TAKAMI, HIDEKI
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Clinical evaluation of cefmenoxime (CMX, Bestcall® ) was performed against infections associated with hematological, respiratory tract and other disorders. Clinical effectiveness of CMX against severe infectionswith hematological disorders including sepsis, pneumonia, pyelitis and so on was 74. 4% for good responses and against the respiratory tract infections, 96. 2% for good responses was obtained. Neither objective or subjective side effects nor extreme abnormalities in laboratory tests were observed in these patients. It can be concluded, therefore, that CMX is one of the most useful drugs against infectious diseases associated with hematological disorders, respiratory tract and other disorders.
ISSN:0368-2781
2186-5477
DOI:10.11553/antibiotics1968b.39.1250